Gum-based Nanoparticles Targeting for Colon Rectal Cancer: Latest Research and Patents

Recent Adv Drug Deliv Formul. 2023;17(4):255-263. doi: 10.2174/0126673878242191231017095804.

Abstract

Colorectal disease is the third most prevelant cancer in both men and women, with an expected 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer as per American Cancer Society. Targeted medicine delivery is vital in the treatment of colon disorders because it delivers long-term therapeutic results with little side effects. Natural polymer is biocompatible and biodegradable, which enables safety, improves storage, and physiological stability, it is utilized as drug delivery vehicles and has made great strides in recent years. Chitosan, alginate, pectin, guar gum, dextran, hyaluronic acid, and arabinoxylan are examples of natural polysaccharides that are utilized to create nanoparticles. Natural gums serve two purposes: first, they shield the medicine from stomach and intestinal conditions, allowing it to only be released in the colon. In this review, we introduce the different gum particularly used in nanoparticles formulation, and then discuss recent research and the latest patent in the development of gum-based nanoparticles for the treatment of colon rectal cancer.

Keywords: Colon rectal cancer; gum polysaccharide; hyaluronic acid; nanoparticles target drug delivery; natural gums; natural polymer..

Publication types

  • Review

MeSH terms

  • Colonic Diseases*
  • Colorectal Neoplasms*
  • Drug Delivery Systems / methods
  • Female
  • Humans
  • Male
  • Nanoparticles* / therapeutic use
  • Pharmaceutical Preparations
  • Rectal Neoplasms* / drug therapy
  • United States

Substances

  • Pharmaceutical Preparations